Log in to save to my catalogue

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4582981

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

About this item

Full title

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2015-09, Vol.106 (9), p.1130-1136

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Ghrelin is a 28‐amino‐acid peptide that stimulates the release of pituitary growth hormone. Because of its orexigenic effects, ghrelin is being developed as a therapeutic option for postoperative support and treatment of anorexia‐cachexia syndrome of cancer patients. However, ghrelin has a multiplicity of physiological functions, and it also affect...

Alternative Titles

Full title

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4582981

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4582981

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.12725

How to access this item